Allergy and Asthma Medical Group and Research Center

Recent papers from Allergy and Asthma Medical Group and Research Center

1. Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild‐to‐moderate asthmaBritish Journal of Clinical Pharmacology · 2026
2. Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-SJournal of Allergy and Clinical Immunology Global · 2026
3. Clinical characteristics, type 2 comorbidities, and treatment responses in pediatric and adult chronic spontaneous urticaria: A multicenter retrospective cohort study.2026
4. Variable progressive behavior of Klebsiella pneumoniae at different sites of infectionFrontiers in Immunology · 2026
5. Updated Treatment of Non‐Steroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease: How to Decide on Aspirin Therapy After Desensitization or Biologics? When? How? An EAACI Task Force ReportAllergy · 2026
6. “I wish someone said along the way”: Patient perspectives on penicillin allergy evaluation during pregnancyAnnals of Allergy Asthma & Immunology · 2025
7. Updates on Chronic Spontaneous Urticaria: EAACI 2025EMJ Allergy & Immunology · 2025
8. Lung Deposition of Extrafine Versus Nonextrafine Aerosols at Low Inhalation Flow Rates in Adult Asthma Patients: A Composition StudyJournal of Aerosol Medicine and Pulmonary Drug Delivery · 2025
9. Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)The Journal of Allergy and Clinical Immunology In Practice · 2025
10. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine · 2023
11. Re‐tensionable Quadriceps Tendon Repair TechniqueArthroscopy Techniques · 2023
12. Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsThe Journal of Allergy and Clinical Immunology In Practice · 2021
13. Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directionsExpert Opinion on Drug Safety · 2021
14. Meta-analyses of the efficacy of pharmacotherapies and sublingual allergy immunotherapy tablets for allergic rhinitis in adults and childrenRhinology Journal · 2021
15. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyThe Journal of Allergy and Clinical Immunology In Practice · 2020
16. Rate of infection following revision anterior cruciate ligament reconstruction and associated patient‐ and surgeon‐dependent risk factors: Retrospective results from MOON and MARS data collected from 2002 to 2011Journal of Orthopaedic Research® · 2020
17. Effectiveness of beclometasone dipropionate and formoterol in an extrafine particle formulation for asthma therapy depending on patient smoking status: the CASPER noninterventional, observational trial2020
18. Patch Test Clinic Start-up: From Basics to PearlsDermatitis · 2020
19. Unmet needs of children with peanut allergyAnnals of Allergy Asthma & Immunology · 2020
20. Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1Respiratory Research · 2019